These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 27499236)
1. Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis. Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J Phys Med Biol; 2016 Sep; 61(17):6400-12. PubMed ID: 27499236 [TBL] [Abstract][Full Text] [Related]
2. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas. Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581 [TBL] [Abstract][Full Text] [Related]
3. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy. Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825 [TBL] [Abstract][Full Text] [Related]
4. Radiotherapy for non-malignant shoulder syndrome: Is there a risk for radiation-induced carcinogenesis? Mazonakis M; Lyraraki E; Tzedakis A; Damilakis J Phys Med; 2017 Nov; 43():73-78. PubMed ID: 29195566 [TBL] [Abstract][Full Text] [Related]
5. Cancer risk estimates from radiation therapy for heterotopic ossification prophylaxis after total hip arthroplasty. Mazonakis M; Berris T; Lyraraki E; Damilakis J Med Phys; 2013 Oct; 40(10):101702. PubMed ID: 24089892 [TBL] [Abstract][Full Text] [Related]
6. Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma. Mazonakis M; Berris T; Varveris C; Lyraraki E; Damilakis J Med Phys; 2014 May; 41(5):051702. PubMed ID: 24784368 [TBL] [Abstract][Full Text] [Related]
7. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study. Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104 [TBL] [Abstract][Full Text] [Related]
8. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT. Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226 [TBL] [Abstract][Full Text] [Related]
9. Combined partial arthroscopic synovectomy and radiation therapy for diffuse pigmented villonodular synovitis of the knee. Blanco CE; Leon HO; Guthrie TB Arthroscopy; 2001 May; 17(5):527-31. PubMed ID: 11337722 [TBL] [Abstract][Full Text] [Related]
10. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled. Barile A; Sabatini M; Iannessi F; Di Cesare E; Splendiani A; Calvisi V; Masciocchi C Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287 [TBL] [Abstract][Full Text] [Related]
11. MONTE CARLO SIMULATION OF OUT-OF-FIELD ORGAN DOSES AND CANCER RISK IN TANZANIA FOR RADIATION THERAPY OF UNILATERAL RETINOBLASTOMA USING A 60Co UNIT. Suleiman SA; Qi Y; Pi Y; George Xu X Radiat Prot Dosimetry; 2018 May; 179(3):263-270. PubMed ID: 29216393 [TBL] [Abstract][Full Text] [Related]
12. Low-dose external beam radiotherapy as a postoperative treatment for patients with diffuse pigmented villonodular synovitis of the knee: 4 recurrences in 23 patients followed for mean 9 years. Park G; Kim YS; Kim JH; Lee SW; Song SY; Choi EK; Yi SY; Ahn SD Acta Orthop; 2012 Jun; 83(3):256-60. PubMed ID: 22489888 [TBL] [Abstract][Full Text] [Related]
13. Radiotherapy for stage I seminoma of the testis: Organ equivalent dose to partially in-field structures and second cancer risk estimates on the basis of a mechanistic, bell-shaped, and plateau model. Mazonakis M; Varveris C; Lyraraki E; Damilakis J Med Phys; 2015 Nov; 42(11):6309-16. PubMed ID: 26520723 [TBL] [Abstract][Full Text] [Related]
14. [Combined treatment of the diffuse form of pigmented villonodular synovitis]. Ustinova VF; Podliashuk EL; Rodionova SS Med Radiol (Mosk); 1986 Mar; 31(3):27-31. PubMed ID: 3959795 [TBL] [Abstract][Full Text] [Related]
15. External beam radiation therapy enhances local control in pigmented villonodular synovitis. Horoschak M; Tran PT; Bachireddy P; West RB; Mohler D; Beaulieu CF; Kapp DS; Donaldson SS Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):183-7. PubMed ID: 19211195 [TBL] [Abstract][Full Text] [Related]
16. Second cancer risk assessments after involved-site radiotherapy for mediastinal Hodgkin lymphoma. Mazonakis M; Lyraraki E; Damilakis J Med Phys; 2017 Jul; 44(7):3866-3874. PubMed ID: 28493609 [TBL] [Abstract][Full Text] [Related]
17. Peripheral organ doses from radiotherapy for heterotopic ossification of non-hip joints: is there a risk for radiation-induced malignancies? Berris T; Mazonakis M; Kachris S; Damilakis J Phys Med; 2014 May; 30(3):309-13. PubMed ID: 24084192 [TBL] [Abstract][Full Text] [Related]
18. Radiation therapy for stage IIA and IIB testicular seminoma: peripheral dose calculations and risk assessments. Mazonakis M; Berris T; Lyraraki E; Damilakis J Phys Med Biol; 2015 Mar; 60(6):2375-89. PubMed ID: 25716274 [TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of arthroscopy and/or arthrotomy therapy for diffuse pigmented villonodular synovitis of the knee]. Liu D; Li Q; Jiang X; Tang X; Li J Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 May; 26(5):518-21. PubMed ID: 22702040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]